Skip to main content
Caplight Logo









Valar Labs

Valar Labs

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://valarlabs.com/

Last Round

Series A

May 30, 2024

Est. Valuation

$50.51M

Total Funding Raised

$26.15M

Company Overview

Valar Labs is a healthcare technology company that develops AI-powered diagnostic tests to analyze tumor histology slides and provide actionable insights for precision oncology treatment decisions.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Precision Medicine, Medical Imaging, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

computational pathologyAI diagnosticsdigital pathologycancer risk stratificationbladder cancer diagnosticspathology AItreatment response predictionFDA breakthrough deviceprecision oncologybiomarker discoveryclinical laboratory servicesmedtechpathology workflow automationAI-driven pathologyclinical decision support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Valar Labs Comparables

Compare Valar Labs with similar companies based on industry and business-model similarity.

Valar Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ArteraAI
82%
Cellens Inc.
78%
Tempus
78%

Valar Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 30, 2024
SeedApr 1, 2022

Key People

Founding team and executive leadership

Damir Vrabac

Co-Founder & COO

Founding Team

Viswesh Krishna

Co-Founder & CTO

Founding Team

Anirudh Joshi

Co-Founder and CEO

Founding Team

Valar Labs Investors

Notable investors and investment history

Valar Labs investors
InvestorRounds
Andreessen HorowitzSeed, Series A
Romulus CapitalSeed
Pear VCSeed, Series A
TakuraSeed
Koa LabsSeed
Martin VenturesSeed
DCVC (Data Collective)Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2022

    $4.15M round led by Andreessen Horowitz.

Valar Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Valar Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Valar Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range30
Year Founded2021
Last FundingMay 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?